High Tower Advisors, LLC Akebia Therapeutics, Inc. Transaction History

High Tower Advisors, LLC

  • $68.3 Billion
  • Q3 2024

A detailed history of High Tower Advisors, LLC transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 93,350 shares of AKBA stock, worth $202,569. This represents 0.0% of its overall portfolio holdings.

Number of Shares
93,350
Previous 88,350 5.66%
Holding current value
$202,569
Previous $90,000 36.67%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$0.94 - $1.55 $4,700 - $7,750
5,000 Added 5.66%
93,350 $123,000
Q2 2024

Aug 13, 2024
BUY
$0.86 - $1.63 $12,900 - $24,450
15,000 Added 20.45%
88,350 $90,000
Q1 2024

May 06, 2024
SELL
$1.27 - $2.24 $29,210 - $51,520
-23,000 Reduced 23.87%
73,350 $134,000
Q4 2023

Feb 12, 2024
BUY
$0.8 - $1.28 $800 - $1,280
1,000 Added 1.05%
96,350 $119,000
Q3 2023

Nov 08, 2023
BUY
$0.87 - $1.84 $21,750 - $46,000
25,000 Added 35.54%
95,350 $108,000
Q1 2023

May 11, 2023
BUY
$0.56 - $1.15 $6,118 - $12,563
10,925 Added 18.38%
70,350 $39,000
Q4 2022

Feb 08, 2023
BUY
$0.25 - $0.58 $1,850 - $4,292
7,401 Added 14.23%
59,425 $34,000
Q3 2022

Nov 09, 2022
BUY
$0.3 - $0.46 $1,890 - $2,898
6,300 Added 13.78%
52,024 $16,000
Q2 2022

Aug 10, 2022
SELL
$0.32 - $0.67 $946 - $1,981
-2,958 Reduced 6.08%
45,724 $16,000
Q1 2022

May 12, 2022
SELL
$0.72 - $2.93 $7 - $32
-11 Reduced 0.02%
48,682 $35,000
Q3 2021

Nov 12, 2021
SELL
$2.35 - $3.88 $1,057 - $1,746
-450 Reduced 0.92%
48,693 $141,000
Q1 2021

May 10, 2021
SELL
$2.92 - $5.06 $998 - $1,730
-342 Reduced 0.69%
49,143 $167,000
Q4 2020

Feb 10, 2021
SELL
$2.22 - $3.78 $5,665 - $9,646
-2,552 Reduced 4.9%
49,485 $139,000
Q3 2020

Nov 13, 2020
BUY
$2.39 - $13.08 $37,716 - $206,415
15,781 Added 43.53%
52,037 $129,000
Q2 2020

Aug 10, 2020
BUY
$6.67 - $13.58 $3,001 - $6,111
450 Added 1.26%
36,256 $493,000
Q4 2019

Feb 14, 2020
BUY
$3.16 - $6.73 $59,645 - $127,028
18,875 Added 111.48%
35,806 $226,000
Q3 2019

Nov 12, 2019
BUY
$3.55 - $5.4 $2,676 - $4,071
754 Added 4.66%
16,931 $66,000
Q2 2019

Aug 13, 2019
BUY
$4.1 - $8.05 $66,325 - $130,224
16,177 New
16,177 $79,000

Others Institutions Holding AKBA

# of Institutions
124
Shares Held
55M
Call Options Held
291K
Put Options Held
179K
View Full List

About Akebia Therapeutics, Inc.

AKBA Quotes by TradingView
  • Ticker AKBA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 183,848,992
  • Market Cap $399M
  • Description
  • Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...
More about AKBA
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email